Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
Xiaodong Wu(Jiangsu Province Hospital), Hongcai Shang(Beijing University of Chinese Medicine), Ping Lyu(Jiangsu Province Hospital), Gehui Ni(Jiangsu Province Hospital), Lijun Wang(Shanghai University), Ting Zhang(Jiangsu Province Hospital), Xinli Li(Jiangsu Province Hospital), Mengli Chen(Nanjing Medical University), Huiling Cheng(First Affiliated Hospital Zhejiang University), Gui-e Xu(Shanghai University)
Cited by 17
Related Papers
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
|Protein & Cell|2021|179
METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury
|Nature Communications|2022|120
Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
|Scientific Reports|2015|82
Exercise training decreases lactylation and prevents myocardial ischemia–reperfusion injury by inhibiting YTHDF2
|Basic Research in Cardiology|2024|66